TORONTO, Oct. 31, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or the “Company”), a biopharmaceutical company committed to developing innovative therapeutic solutions for underserved mental health conditions, announced today that the Company will participate in two upcoming conferences in November. Hanson Wade 5th Annual Neuropsychiatric &


Previous articleNuminus to Participate in Wonderland: Miami on November 3-5, 2022
Next articleNuminus Re-Launches “Psychedelic Therapy Frontiers” Podcast with additional hosts and topics